Zenith Therapeutics is redefining drug discovery through a new approach to protein degradation. Our team has identified key ligases that govern the turnover of hard-to-drug transcription factors and convert these pairs into druggable protein-protein interfaces. With an initial focus on oncology and immune modulation, we are committed to advancing highly impactful precision medicines across multiple disease areas.
Headquartered in Basel, Switzerland, Zenith was created by Ridgeline Discovery, a Versant Ventures Discovery Engine, and is backed by leading investors in the biotech sector.
We are looking for an experienced small molecule screening expert to join our growing drug discovery team at Zenith. You will lead and implement our internal screening setup to identify and optimize molecular glues, work hand in hand with our biology team to develop and optimize assays and be accountable for compound logistics and interactions with external partners.
To apply, please submit your completed application form along with your CV, cover letter, and reference letters (Arbeitszeugnisse).